| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,172,974 | 1 | 2 |
Sells | $19,381,243 | 46 | 98 |
| WELLS DAVID B | director | 1 | $1.17M | 0 | $0 | $1.17M |
| Perez Garcia Andrea G | director | 0 | $0 | 1 | $97,925 | $-97,925 |
| Autor Deborah M. | Chief Policy Officer | 0 | $0 | 2 | $726,080 | $-726,080 |
| Becklund Irene | PAO | 0 | $0 | 4 | $815,797 | $-815,797 |
| Elshenawy Mohamed | CTO | 0 | $0 | 2 | $1.17M | $-1.17M |
| Carroll Patrick Harrison | Chief Medical Officer | 0 | $0 | 2 | $1.2M | $-1.2M |
| Boughton Soleil | Chief Legal Officer | 0 | $0 | 11 | $1.94M | $-1.94M |
| Chi Michael | Chief Operating Officer | 0 | $0 | 4 | $3.75M | $-3.75M |
| Okupe Oluyemi | Chief Financial Officer | 0 | $0 | 20 | $9.69M | $-9.69M |
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual …
Over the last 12 months, insiders at Hims & Hers Health, Inc. have bought $1.17M and sold $19.38M worth of Hims & Hers Health, Inc. stock.
On average, over the past 5 years, insiders at Hims & Hers Health, Inc. have bought $1.24M and sold $94.57M worth of stock each year.
Highest buying activity among insiders over the last 12 months: WELLS DAVID B (director) — $1.17M.
The last purchase of 48,400 shares for transaction amount of $1.17M was made by WELLS DAVID B (director) on 2026‑05‑26.
| 2026-10-28 | Sale | Boughton Soleil | Chief Legal Officer | 3,462 0.0014% | $27.60 | $95,551 | -8.97% | |
| 2026-10-14 | Sale | Boughton Soleil | Chief Legal Officer | 3,461 0.0016% | $29.06 | $100,577 | +1.41% | |
| 2026-10-01 | Sale | Okupe Oluyemi | Chief Financial Officer | 2,000 0.0009% | $29.70 | $59,400 | -0.58% | |
| 2026-09-30 | Sale | Boughton Soleil | Chief Legal Officer | 3,461 0.0015% | $29.17 | $100,957 | -2.08% | |
| 2026-09-22 | Sale | Okupe Oluyemi | Chief Financial Officer | 29,277 0.014% | $29.95 | $876,846 | -4.14% | |
| 2026-09-17 | Sale | Okupe Oluyemi | Chief Financial Officer | 12,313 0.0057% | $28.82 | $354,861 | +4.73% | |
| 2026-09-16 | Sale | Boughton Soleil | Chief Legal Officer | 6,236 0.0028% | $27.86 | $173,735 | +4.18% | |
| 2026-09-15 | Sale | Chi Michael | Chief Operating Officer | 14,027 0.0064% | $28.39 | $398,227 | +4.60% | |
| 2026-09-15 | Sale | Elshenawy Mohamed | CTO | 7,954 0.0036% | $28.39 | $225,814 | +4.60% | |
| 2026-09-02 | Sale | Boughton Soleil | Chief Legal Officer | 3,458 0.0015% | $28.33 | $97,965 | +0.07% | |
| 2026-08-19 | Sale | Boughton Soleil | Chief Legal Officer | 25,111 0.01% | $27.55 | $691,808 | -7.24% | |
| 2026-08-19 | Sale | Okupe Oluyemi | Chief Financial Officer | 4,938 0.0021% | $29.99 | $148,111 | -7.24% | |
| 2026-08-18 | Sale | Autor Deborah M. | Chief Policy Officer | 16,773 0.0076% | $27.85 | $467,128 | +5.59% | |
| 2026-08-17 | Sale | Okupe Oluyemi | Chief Financial Officer | 9,388 0.0039% | $27.89 | $261,802 | +0.80% | |
| 2026-07-17 | Sale | Okupe Oluyemi | Chief Financial Officer | 7,163 0.0031% | $31.99 | $229,168 | -11.05% | |
| 2026-07-06 | Sale | Okupe Oluyemi | Chief Financial Officer | 7,163 0.0031% | $36.49 | $261,351 | -23.41% | |
| 2026-06-22 | Sale | Okupe Oluyemi | Chief Financial Officer | 18,197 0.0083% | $34.03 | $619,217 | -12.03% | |
| 2026-06-18 | Sale | Okupe Oluyemi | Chief Financial Officer | 55,383 0.0246% | $35.09 | $1.94M | -16.72% | |
| 2026-06-18 | Sale | Carroll Patrick Harrison | Chief Medical Officer | 23,726 0.0105% | $35.00 | $830,410 | -16.72% | |
| 2026-06-17 | Sale | Chi Michael | Chief Operating Officer | 14,027 0.0063% | $31.50 | $441,851 | -7.31% |
| Okupe Oluyemi | Chief Financial Officer | 234527 0.1043% | $6.03M | 1 | 60 | +79.72% |
| WELLS DAVID B | director | 224417 0.0998% | $5.77M | 5 | 4 | <0.0001% |
| Payne Christopher D | director | 110000 0.0489% | $2.83M | 1 | 0 | +39.98% |
| Dudum Andrew | Chief Executive Officer | 95315 0.0424% | $2.45M | 2 | 58 | <0.0001% |
| Manuel Anja | director | 5000 0.0022% | $128,500.00 | 2 | 0 | +88.33% |
| Maltz Jules A. | 10 percent owner | 0 0% | $0 | 2 | 3 | +68.81% |
| Increased Positions | 279 | +44.86% | 22M | +10.23% |
| Decreased Positions | 286 | -45.98% | 49M | -23% |
| New Positions | 99 | New | 4M | New |
| Sold Out Positions | 129 | Sold Out | 14M | Sold Out |
| Total Postitions | 615 | -1.13% | 185M | -12.77% |
| Blackrock, Inc. | $840,122.00 | 11.48% | 25.15M | +396,440 | +1.6% | 2025-09-30 |
| Vanguard Group Inc | $652,097.00 | 8.91% | 19.52M | +844,991 | +4.53% | 2025-09-30 |
| Capital World Investors | $627,547.00 | 8.58% | 18.78M | +223,892 | +1.21% | 2025-09-30 |
| Jpmorgan Chase & Co | $594,233.00 | 8.12% | 17.79M | +15M | +549.04% | 2025-09-30 |
| Farallon Capital Management Llc | $359,052.00 | 4.91% | 10.75M | +3M | +30.84% | 2025-09-30 |
| Goldman Sachs Group Inc | $308,158.00 | 4.21% | 9.22M | +1M | +12.99% | 2025-09-30 |
| Renaissance Technologies Llc | $303,926.00 | 4.15% | 9.1M | +2M | +32.42% | 2025-09-30 |
| Morgan Stanley | $243,094.00 | 3.32% | 7.28M | +2M | +31.6% | 2025-09-30 |
| State Street Corp | $239,657.00 | 3.28% | 7.17M | +132,384 | +1.88% | 2025-09-30 |
| Geode Capital Management, Llc | $163,736.00 | 2.24% | 4.9M | +154,733 | +3.26% | 2025-09-30 |